TG Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +100.0% | -50.0% | -23.9% | -13.0% | -25.3% | +282.3% | -32.3% | -58.1% | +12.0% | -19.7% | -46.0% | -78.8% | -38.5% | -100.0% | – | +379.6% | +248.8% | +293.1% | +307.5% | +30.8% | +6.9% | +220.5% | +32.6% | +32.1% | +4.3% | -17.9% | -33.8% | -78.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -72.3% | -23.8% | -38.5% | -60.2% | +3,856.6% | +52.0% | +305.6% | -25.6% | -52.2% | +112.3% | -19.2% | -12.0% | +608.3% | -23.7% | -68.7% | +97.7% | +12.1% | +52.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +2,913.5% | +7.0% | +661.0% | -26.3% | -52.9% | +117.2% | -19.9% | -10.7% | +607.2% | -25.1% | -68.6% | – | – | – | |
| – | – | -200.0% | – | – | -222.0% | – | -373.1% | – | +621.6% | -80.0% | -101.4% | – | – | – | +114.1% | +68.4% | +476.2% | -248.7% | – | +324.5% | -2.4% | +224.2% | -9.3% | -178.4% | – | – | – | – | – | |
| – | +100.0% | +0.0% | -50.0% | +71.4% | -36.8% | -95.0% | +20.0% | +2,010.8% | -71.4% | -6.3% | -75.3% | -1.8% | -100.0% | – | -100.0% | – | +306.1% | +226.9% | +127.3% | +714.8% | -99.4% | +3,941.3% | +45.6% | +172.5% | +12.3% | -96.5% | -100.0% | – | +375.6% | |
| – | +100.0% | +0.0% | -50.0% | +218.0% | – | -100.2% | – | -2,719.7% | – | -72.1% | -100.9% | -1.8% | – | – | -98.0% | -113.5% | +351,976.6% | +272.7% | +34.5% | – | -130.9% | – | -160.8% | +3,313.6% | -98.6% | +5,928.0% | +153.1% | -98.0% | – | |
| – | – | – | – | – | – | -18.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +20.6% | – | – | +330.0% | – | – | – | – | – | – | – | -100.9% | +77.2% | – | -0.8% | -92.7% | +2,557.5% | -15.0% | +54.0% | +288.4% | -99.6% | -76.0% | -100.0% | – | +941.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -85.7% | -87.0% | – | +0.0% | -2.7% | +37.0% | -2.5% | -102.5% | – | +449.0% | -100.0% | |
| – | +715.4% | -99.1% | – | – | -22.8% | -107.3% | – | -62.3% | +245.0% | -100.1% | – | -50.3% | -75.4% | +99.0% | +413.2% | +21.1% | +234.4% | +72.6% | +0.1% | -92.7% | +2,564.7% | -15.0% | +79.7% | +232.9% | -93.9% | -100.9% | – | +76.8% | -169.8% | |
| – | – | -142.9% | – | – | – | – | – | -214.3% | – | -176.2% | – | – | – | – | +2,016.1% | -31.2% | +258.2% | -36.6% | -104.3% | – | – | -144.5% | – | +523.6% | -157.7% | – | – | – | -215.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.